Cardioprotection During Chemotherapy
نویسندگان
چکیده
منابع مشابه
SPOTLIGHT REVIEW Cardioprotection during cardiac surgery
Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide. For a large number of patients with CHD, coronary artery bypass graft (CABG) surgery remains the preferred strategy for coronary revascularization. Over the last 10 years, the number of high-risk patients undergoing CABG surgery has increased significantly, resulting in worse clinical outcomes in this patien...
متن کاملCardioprotection during Adult and Pediatric Open Heart Surgery
1Bristol Heart Institute, Level 7, Bristol Royal Infirmary, Faculty of Medicine & Dentistry, University of Bristol, Bristol, UK 2Cardiothoracic Surgery, The Chinese University of Hong Kong, Faculty of Medicine, Prince of Wales Hospital, Shatin, Hong Kong 3Cardiovascular Surgery, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, Tokyo 113-8603, Japan 4Congenital Heart Surgery, Royal Hospital for C...
متن کاملCardioprotection with sevoflurane during off-pump coronary artery surgery
Methods Study included 48 patients induced in anesthesia with 8 vol.% sevoflurane within high 100% oxygen flow (5 L/min). Patients randomized into two groups: sevoflurane group (n = 24) in which anesthesia maintained with 1 MAC of endtidal sevoflurane concentration, and propofol group (n = 24), in which anesthesia maintained with continuous propofol infusion in doses of 2 to 3 mg/kg/h. Inclusio...
متن کاملInjection of isolated mitochondria during early reperfusion for cardioprotection.
Previously, we demonstrated that ischemia induces mitochondrial damage and dysfunction that persist throughout reperfusion and impact negatively on postischemic functional recovery and cellular viability. We hypothesized that viable respiration-competent mitochondria, isolated from tissue unaffected by ischemia and then injected into the ischemic zone just before reperfusion, would enhance post...
متن کاملPerioperative cardioprotection
Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no "magic bullet", pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2013
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2013.02.073